Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Plecanatide in CIC
NCT01919697Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Aug 2013
- Primary completion
- Jan 2016
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of plecanatide in chronic idiopathic constipation (CIC), sponsored by Valeant Pharmaceuticals. Started Aug 2013; status: completed.
02
Drugs
plecanatide
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT01919697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01919697.